High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myelomaCAVO, M; BANDINI, G; MOTTA, M et al.Bone marrow transplantation (Basingstoke). 1998, Vol 22, Num 1, pp 27-32, issn 0268-3369Article

Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+ cells to support single or tandem high-dose chemotherapyLEMOLI, R. M; MARTINELLI, G; TURA, S et al.Blood. 2000, Vol 95, Num 7, pp 2234-2239, issn 0006-4971Article

Molecular monitoring of minimal residual disease in patients in long-term complete remission after allogeneic stem cell transplantation for multiple myelomaCAVO, M; TERRAGNA, C; TURA, S et al.Blood. 2000, Vol 96, Num 1, pp 355-357, issn 0006-4971Article

Autologous Transplantation and Maintenance Therapy in Multiple MyelomaPALUMBO, A; CAVALLO, F; GENUARDI, M et al.The New England journal of medicine. 2014, Vol 371, Num 10, pp 895-905, issn 0028-4793, 11 p.Article

Long-term follow-up after autologous stem cell transplantation for light- and heavy-chain deposition diseaseBRIOLI, A; ZAMAGNI, E; CAVO, M et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 9, pp 1248-1249, issn 0268-3369, 2 p.Article

Neuropathy in multiple myeloma treated with thalidomide : A prospective studyPLASMATI, R; PASTORELLI, F; MICHELUCCI, R et al.Neurology. 2007, Vol 69, Num 6, pp 573-581, issn 0028-3878, 9 p.Article

Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failureTOSI, P; ZAMAGNI, E; RONCONI, S et al.Leukemia. 2000, Vol 14, Num 7, pp 1310-1313, issn 0887-6924Article

In vitro treatment with retinoids decreases bcl-2 protein expression and enhances dexamethasone-induced cytotoxicity and apoptosis in multiple myeloma cellsTOSI, P; PELLACANI, A; VISANI, G et al.European journal of haematology. 1999, Vol 62, Num 3, pp 143-148, issn 0902-4441Article

Results of a fludarabine induction and α-interferon maintenance protocol in pretreated patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphomaZINZANI, P. L; BENDANDI, M; MAGAGNOLI, M et al.European journal of haematology. 1997, Vol 59, Num 2, pp 82-88, issn 0902-4441Article